Companies Dominating the Subdermal Contraceptive Implants Market
- Merck & Co., Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Shanghai Dahua Pharmaceutical Co., Ltd,
- Bayer AG
- Wyeth Pharmaceuticals
- Baxter
- Gerresheimer AG
- Theramex
- Contraline, Inc.
- Pfizer, Inc.
- Novartis AG
- Schott AG
- Eli Lilly and Company
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of subdermal contraceptive implants is assessed at USD 1.11 billion.
The subdermal contraceptive implants market size was over USD 1.08 billion in 2024 and is likely to reach USD 1.73 billion by the end of 2037, witnessing around 3.7% CAGR during the forecast period i.e., between 2025-2037. Rising count of unintended pregnancies and the rising governmental initiative to utilize contraceptive procedures will drive the market growth.
North America industry is estimated to hold largest revenue share 55% by 2037, impelled by availability of contraceptive implants in the region.
The major players in the market are Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals, Baxter, Gerresheimer AG, Pfizer, Inc., Novartis AG, Schott AG, Eli Lilly and Company, and others.
